张永亭
[摘要] 目的 探討超声联合钼靶、MRI检查对早期乳腺癌诊断的价值。 方法 随机选取2015年1月～2018年7月在我院行早期乳腺癌治疗的患者共50例，所有患者均行超声联合钼靶、MRI检查，对比分析3种检查方法的特异性、敏感性、准确性。 结果 超声联合钼靶、MRI诊断恶性42例，良性8例;超声诊断恶性31例，良性19例;钼靶诊断恶性25例，良性25例;MRI诊断恶性43例，良性7例。MRI检查方式的特异性、敏感性、准确性分别为66.00%、64.00%、74.00%;钼靶检查方式的特异性、敏感性、准确性分别为70.00%、62.00%、66.00%;超声检查方式的特异性、敏感性、准确性分别为50.00%、56.00%、40.00%;超声联合钼靶、MRI检查方式的特异性、敏感性、准确性分别为80.00%、82.00%、78.00%，超声联合钼靶、MRI检查方式的特异性、敏感性、准确性均高于MRI、钼靶、超声检查方式，组间差异有统计学意义（P<0.05）。 结论 给予早期乳腺癌患者采用超声联合钼靶、MRI检查利于提升诊断准确率，为临床治疗人员提供强有力的诊断依据，值得临床广泛推广应用。
[关键词] 超声;钼靶;MRI;早期乳腺癌;医学影像
[中图分类号] R737.9;R445;R730.44 [文献标识码] B [文章编号] 1673-9701（2019）17-0108-04
[Abstract] Objective To explore the value of ultrasound combined with molybdenum target and MRI in the diagnosis of early breast cancer. Methods A total of 50 patients who underwent early breast cancer treatment in our hospital from January 2015 to July 2018 were randomly selected. All patients were treated with ultrasound combined with molybdenum target and MRI. The specificity， sensitivity and accuracy of the three methods were compared and analyzed. Results Of the results of ultrasound combined with molybdenum target and MRI， 42 cases were malignant and 8 cases were benign; The results of ultrasound diagnosis were malignant in 31 cases and benign in 19 cases; results of molybdenum target diagnosis were malignant in 25 cases and benign in 25 cases; and MRI diagnosis showed malignancy in 43 cases and benign in 7 cases. The specificity， sensitivity and accuracy of MRI were 66.00%， 64.00%， and 74.00%， respectively. The specificity， sensitivity， and accuracy of molybdenum target were 70.00%， 62.00%， and 66.00%， respectively. The specificity， sensitivity and accuracy of the ultrasound examination were 50.00%， 56.00%， and 40.00%， respectively. The specificity， sensitivity， and accuracy of ultrasound combined with molybdenum target and MRI were 80.00%， 82.00%， and 78.00%， respectively. The specificity， sensitivity and accuracy of ultrasound combined with molybdenum target and MRI were higher than those of MRI， molybdenum target or ultrasonography. The differences were statistically significant（P<0.05）. Conclusion In patients with early breast cancer， the use of ultrasound combined with molybdenum target and MRI can improve the diagnostic accuracy and provide a strong diagnostic basis for clinical staff， which is worthy of widespread clinical application.
[Key words] Ultrasound; Molybdenum target; MRI; Early breast cancer; Medical imaging
